Measuring the health utility of chronic eustachian tube dysfunction
| Autor: | Katherine Niekamp, Marta Kulich, Meron Teklu, Kristin Brindisi, Caroline P.E. Price, Bruce K. Tan, Alan G. Micco, Andrew Ferski |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male medicine.medical_specialty Visual analogue scale Disease 03 medical and health sciences 0302 clinical medicine Cost of Illness Quality of life Internal medicine medicine Humans Prospective Studies 030212 general & internal medicine Ear Diseases 030223 otorhinolaryngology Sinusitis Prospective cohort study Aged business.industry Eustachian Tube Reflux Evidence-based medicine Middle Aged Eustachian tube dysfunction medicine.disease Otorhinolaryngology Chronic Disease Female Self Report business |
| Zdroj: | The Laryngoscope. 130 |
| ISSN: | 1531-4995 0023-852X |
| Popis: | OBJECTIVE To assess the health utility of chronic Eustachian tube dysfunction (ETD). METHODS This is a prospective study of 53 patients with chronic ETD recruited from a tertiary clinic from April 2017 to July 2018. The 7-Item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) was administered, and health utility was evaluated using the EuroQol-5 Dimensions-3 Level Instrument (EQ-5D-3L), the visual analogue scale (VAS), time tradeoff (TTO), and standard gamble (SG). Participants were grouped into medical or procedural management groups. One-week follow-up included repeated health utility measures and ETDQ-7. RESULTS Fifty-three patients were included in the final analysis. Of those, 34 were managed medically, and 19 received myringotomies ± PE tubes. The mean baseline ETDQ-7 was 4.26 ± 1.31; whereas health utility measures were different depending on the method utilized: EQ-5D-3L 0.90 ± 0.11; VAS 0.76 ± 0.21; TTO 0.85 ± 0.23; and SG 0.94 ± 0.11 (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text